These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22541291)

  • 1. Human and mouse model cognitive phenotypes in Down syndrome: implications for assessment.
    Edgin JO; Mason GM; Spanò G; Fernández A; Nadel L
    Prog Brain Res; 2012; 197():123-51. PubMed ID: 22541291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synaptic and cognitive abnormalities in mouse models of Down syndrome: exploring genotype-phenotype relationships.
    Belichenko PV; Kleschevnikov AM; Salehi A; Epstein CJ; Mobley WC
    J Comp Neurol; 2007 Oct; 504(4):329-45. PubMed ID: 17663443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways.
    Rachidi M; Lopes C
    Eur J Paediatr Neurol; 2008 May; 12(3):168-82. PubMed ID: 17933568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippocampal network alterations in Alzheimer's disease and Down syndrome: from structure to therapy.
    Sanchez MM; Moghadam S; Naik P; Martin KJ; Salehi A
    J Alzheimers Dis; 2011; 26 Suppl 3():29-47. PubMed ID: 21971449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurobiological elements of cognitive dysfunction in down syndrome: exploring the role of APP.
    Millan Sanchez M; Heyn SN; Das D; Moghadam S; Martin KJ; Salehi A
    Biol Psychiatry; 2012 Mar; 71(5):403-9. PubMed ID: 21945306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral Phenotyping for Down Syndrome in Mice.
    Roper RJ; Goodlett CR; Martínez de Lagrán M; Dierssen M
    Curr Protoc Mouse Biol; 2020 Sep; 10(3):e79. PubMed ID: 32780566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in vivo Down syndrome genomic library in mouse.
    Herault Y; Duchon A; Velot E; Maréchal D; Brault V
    Prog Brain Res; 2012; 197():169-97. PubMed ID: 22541293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse models of cognitive disabilities in trisomy 21 (Down syndrome).
    Roubertoux PL; Carlier M
    Am J Med Genet C Semin Med Genet; 2010 Nov; 154C(4):400-16. PubMed ID: 20981769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memantine normalizes several phenotypic features in the Ts65Dn mouse model of Down syndrome.
    Rueda N; Llorens-Martín M; Flórez J; Valdizán E; Banerjee P; Trejo JL; Martínez-Cué C
    J Alzheimers Dis; 2010; 21(1):277-90. PubMed ID: 20421694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Socio-cognitive understanding: a strength or weakness in Down's syndrome?
    Wishart JG
    J Intellect Disabil Res; 2007 Dec; 51(Pt 12):996-1005. PubMed ID: 17991007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic pathology in mental retardation: from molecular genetics to neurobiology.
    Dierssen M; Ramakers GJ
    Genes Brain Behav; 2006; 5 Suppl 2():48-60. PubMed ID: 16681800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of brain circuits in Down syndrome murine models.
    Gotti S; Caricati E; Panzica G
    J Chem Neuroanat; 2011 Dec; 42(4):317-26. PubMed ID: 21946025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive and pharmacological insights from the Ts65Dn mouse model of Down syndrome.
    Ruparelia A; Pearn ML; Mobley WC
    Curr Opin Neurobiol; 2012 Oct; 22(5):880-6. PubMed ID: 22658745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is it possible to improve neurodevelopmental abnormalities in Down syndrome?
    Bartesaghi R; Guidi S; Ciani E
    Rev Neurosci; 2011; 22(4):419-55. PubMed ID: 21819263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down syndrome: genes, model systems, and progress towards pharmacotherapies and clinical trials for cognitive deficits.
    Busciglio J; Capone G; O'Bryan J; Gardiner KJ
    Cytogenet Genome Res; 2013; 141(4):260-71. PubMed ID: 24008277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mental retardation in Down syndrome: from gene dosage imbalance to molecular and cellular mechanisms.
    Rachidi M; Lopes C
    Neurosci Res; 2007 Dec; 59(4):349-69. PubMed ID: 17897742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mice transgenic for reduced folate carrier: an animal model of Down syndrome?
    Höger J; Patterson D; Höger H; Shim KS; Bubna-Littitz H; Lubec G
    Amino Acids; 2009 Feb; 36(2):349-57. PubMed ID: 18414976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aneuploidy: from a physiological mechanism of variance to Down syndrome.
    Dierssen M; Herault Y; Estivill X
    Physiol Rev; 2009 Jul; 89(3):887-920. PubMed ID: 19584316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and cellular mechanisms elucidating neurocognitive basis of functional impairments associated with intellectual disability in Down syndrome.
    Rachidi M; Lopes C
    Am J Intellect Dev Disabil; 2010 Mar; 115(2):83-112. PubMed ID: 20441388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice.
    Richtsmeier JT; Baxter LL; Reeves RH
    Dev Dyn; 2000 Feb; 217(2):137-45. PubMed ID: 10706138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.